Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,825,600 | 973,500 | 8,075,300 | 5,846,300 | 4,214,100 |
| Depreciation Amortization | 148,700 | 74,300 | 286,200 | 211,700 | 138,500 |
| Income taxes - deferred | -381,000 | -225,000 | -147,100 | 58,800 | 51,800 |
| Accounts receivable | 875,100 | 1,197,500 | -1,927,400 | -1,342,900 | -2,883,900 |
| Other Working Capital | 41,900 | 823,200 | -1,916,500 | -1,561,100 | -3,024,300 |
| Other Operating Activity | 155,800 | -741,800 | 2,710,800 | 1,496,000 | 2,799,000 |
| Operating Cash Flow | $2,666,100 | $2,101,700 | $7,081,300 | $4,708,800 | $1,295,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,593,500 | -1,563,500 | -4,832,800 | -2,975,000 | -669,400 |
| PPE Investments | -295,400 | -141,800 | -551,900 | -397,000 | -263,800 |
| Net Acquisitions | -230,300 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-2,119,200 | $-1,705,300 | $-5,384,700 | $-3,372,000 | $-933,200 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 828,400 | 521,600 | 1,672,300 | 1,129,600 | 308,200 |
| Common Stock Repurchased | -864,800 | -456,900 | -2,678,100 | -1,228,800 | -792,800 |
| Financing Cash Flow | $-36,400 | $64,700 | $-1,005,800 | $-99,200 | $-484,600 |
| Beginning Cash Position | 2,898,100 | 2,898,100 | 2,207,300 | 2,207,300 | 2,207,300 |
| End Cash Position | 3,408,600 | 3,359,200 | 2,898,100 | 3,444,900 | 2,084,700 |
| Net Cash Flow | $510,500 | $461,100 | $690,800 | $1,237,600 | $-122,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,666,100 | 2,101,700 | 7,081,300 | 4,708,800 | 1,295,200 |
| Capital Expenditure | -295,400 | -141,800 | -551,900 | -397,000 | -263,800 |
| Free Cash Flow | 2,370,700 | 1,959,900 | 6,529,400 | 4,311,800 | 1,031,400 |